These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6506704)

  • 1. [Composition of plasma lipoproteins and clinical indicators of the progression of arteriosclerosis in patients with primary hyperlipoproteinemia and different degrees of lipid change in the soft palate].
    Markiewicz M; Dubejko J; Rymar B; Koziara Z; Horubała-Bielak G
    Wiad Lek; 1984 Jun; 37(11):831-5. PubMed ID: 6506704
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipid metabolism disorders and soft palate lipid changes in myocardial infarct].
    Dubejko J; Markiewicz M; Michałowski R; Kutarski A
    Pol Tyg Lek; 1980 Aug; 35(32):1217-9. PubMed ID: 7433204
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 4. High density lipoprotein and arteriosclerosis. Different patterns in primary hypothyroidism and type IIa hyperlipoproteinemia.
    Brook JG; Aviram M; Luboshitzky R; Barzilai D
    Isr J Med Sci; 1981 May; 17(5):318-22. PubMed ID: 7263188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arteriosclerosis indices of lipid and lipoprotein metabolism].
    Reuter W; Herrmann W; Voigt H; Köhler H; Schütz C; Hanf S; Lindhofer HG; Kuklinski B
    Z Arztl Fortbild (Jena); 1984; 78(6):239-41. PubMed ID: 6730538
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of medium-term probucol treatment on plasma lipids and lipoproteins. 16 cases of type IIa and IIb hyperlipoproteinaemia (author's transl)].
    Rouffy J; Chanu B; Bakir R; Goy-Loepper J; Saya C
    Nouv Presse Med; 1980 Oct; 9(40):3014-7. PubMed ID: 7443443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipoproteins in plasma and fats in nutrition in the pathogenesis of coronary heart disease. Remarks on the causes and limits of the lipid theory].
    Zöllner N; Keller C
    Internist (Berl); 1984 May; 25(5):261-7. PubMed ID: 6376406
    [No Abstract]   [Full Text] [Related]  

  • 8. [Modification of serum lipoproteins by soy bean proteins].
    Richter WO; Weisweiler P; Schwandt P
    MMW Munch Med Wochenschr; 1981 Nov; 123(46):1755-6. PubMed ID: 6796844
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs.
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Artery; 1980; 8(2):113-9. PubMed ID: 7458676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis].
    Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R
    Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J; Bar-On H; Shafrir E
    Isr J Med Sci; 1981 Nov; 17(11):1001-8. PubMed ID: 7319786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias.
    Canzler H; Bojanovski D
    Artery; 1980; 8(2):171-8. PubMed ID: 7458684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipid deposits in the soft palate and the clinical aspects of myocardial infarct].
    Dubejko J; Markiewicz M; Michałowski R; Kutarski A
    Wiad Lek; 1980 Aug; 33(16):1283-8. PubMed ID: 7434774
    [No Abstract]   [Full Text] [Related]  

  • 14. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V; Klör HU; Wechsler JG; Ditschuneit H
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [One year fenofibrate treatment of type II primary hyperlipidaemia. Effects on lipoproteins and biological tolerance (author's transl)].
    Drouin P; Méjean L; Lambert D; Wülfert E; Debry G
    Nouv Presse Med; 1980 Dec; 9(49):3753-7. PubMed ID: 7208342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Sadamin on lipid metabolism in patients with obliterative arteriosclerosis of lower limbs].
    Kiersnowska B; Bielawiec M; Lukjan H; Grabowski R; Korfel B
    Pol Tyg Lek; 1972 Jan; 27(4):133-5. PubMed ID: 5010169
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biochemical diagnosis of hereditary hyperlipoproteinemias].
    Tvorogova MG; Rozhkova TA; Alidzhanova KhG; Semenova OA; Sobolev AV; Kukharchuk VV; Titov VN
    Ter Arkh; 1998; 70(4):9-15. PubMed ID: 9612894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholesterol and triglyceride plasma levels in patients with primary hyperlipoproteinemia. Decline after short-term i.v. glucagon administration].
    Andĕl M; Brodan V; Kucerová L; Grafnetter D; Kuhn E; Veselková A
    Cas Lek Cesk; 1980 May; 119(22):616-21. PubMed ID: 7427980
    [No Abstract]   [Full Text] [Related]  

  • 20. [Obstructive peripheral athero-arteriosclerotic vascular diseases. Apparent pathogenetic role of hormono-metabolic changes].
    De Carolis GD; Salpietro V; Giordano L; Granatelli G; Contini V
    Minerva Med; 1981 Mar; 72(9):539-54. PubMed ID: 7017498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.